These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34422136)

  • 1. A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT).
    Li J; Cao T; Wei Y; Zhang N; Zhou Z; Wang Z; Li J; Zhang Y; Wang S; Wang P; Cheng N; Ye L; Li M; Yu Y; Ding C; Tan Z; Zhan B; He Q; Bao H; Wu Y; Liu L; Li J; Xu X; Cheng X; Huang X
    Dis Markers; 2021; 2021():6258865. PubMed ID: 34422136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase A2 is an Inflammatory Predictor in Cardiovascular Diseases: Is there any Spacious Room to Prove the Causation?
    Santoso A; Heriansyah T; Rohman MS
    Curr Cardiol Rev; 2020; 16(1):3-10. PubMed ID: 31146670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between Levels of Serum Lipoprotein-Associated Phospholipase A2 and Soluble Suppression of Tumorigenicity 2 and Condition of Acute Heart Failure Patients and Their Predictive Value for Prognosis.
    Zhang J; Wang L; Zhao Z; Li L; Xia Y
    J Healthc Eng; 2021; 2021():1525190. PubMed ID: 34956555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-associated phospholipase A2: how effective as a risk marker of cardiovascular disease and as a therapeutic target?
    Ahmed MS; Ji JZ; Meng QH
    Inflamm Allergy Drug Targets; 2011 Aug; 10(4):236-46. PubMed ID: 21539512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A2 and its relationship with markers of subclinical cardiovascular disease: A systematic review.
    Younus A; Humayun C; Ahmad R; Ogunmoroti O; Kandimalla Y; Aziz M; Malik R; Saand AR; Valdes C; Badlani R; Younus MA; Ali SS; Chen Y; Nasir K
    J Clin Lipidol; 2017; 11(2):328-337. PubMed ID: 28502488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease.
    Sofogianni A; Alkagiet S; Tziomalos K
    Curr Pharm Des; 2018; 24(3):291-296. PubMed ID: 29332572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker.
    Vittos O; Toana B; Vittos A; Moldoveanu E
    Biomarkers; 2012 Jun; 17(4):289-302. PubMed ID: 22401038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.
    Garg PK; McClelland RL; Jenny NS; Criqui MH; Greenland P; Rosenson RS; Siscovick DS; Jorgensen N; Cushman M
    Atherosclerosis; 2015 Jul; 241(1):176-82. PubMed ID: 26004387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.
    Wallentin L; Held C; Armstrong PW; Cannon CP; Davies RY; Granger CB; Hagström E; Harrington RA; Hochman JS; Koenig W; Krug-Gourley S; Mohler ER; Siegbahn A; Tarka E; Steg PG; Stewart RA; Weiss R; Östlund O; White HD;
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27329448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-associated phospholipase A2 predicted cardiovascular disease in obstructive sleep apnea syndrome.
    Xu C; Yu F; Mao S; Shi Y; Li Q; Fang S; Tan Y; Gu W; Ye L
    Respir Med; 2020 Mar; 163():105881. PubMed ID: 32056835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of Lipoprotein-Associated Phospholipase A
    Tibuakuu M; Kianoush S; DeFilippis AP; McEvoy JW; Zhao D; Guallar E; Ballantyne CM; Hoogeveen RC; Blaha MJ; Michos ED
    Am J Cardiol; 2018 May; 121(9):1056-1064. PubMed ID: 29525060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients.
    De Mauri A; Vidali M; Chiarinotti D; Bellomo G; Rolla R
    J Nephrol; 2019 Apr; 32(2):283-288. PubMed ID: 30168082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China.
    Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X
    Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.
    Ross Eckard A; Longenecker CT; Jiang Y; Debanne SM; Labbato D; Storer N; McComsey GA
    HIV Med; 2014 Oct; 15(9):537-46. PubMed ID: 24650269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome-There is Meat on the Bone.
    Aleksova A; Paldino A; Beltrami AP; Padoan L; Iacoviello M; Sinagra G; Emdin M; Maisel AS
    J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30813357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study.
    Tsimikas S; Willeit J; Knoflach M; Mayr M; Egger G; Notdurfter M; Witztum JL; Wiedermann CJ; Xu Q; Kiechl S
    Eur Heart J; 2009 Jan; 30(1):107-15. PubMed ID: 19019993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A2.
    McConnell JP; Hoefner DM
    Clin Lab Med; 2006 Sep; 26(3):679-97, vii. PubMed ID: 16938590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lp-PLA2 and sPLA2: cardiovascular biomarkers].
    Ait-Oufella H; Mallat Z; Tedgui A
    Med Sci (Paris); 2014 May; 30(5):526-31. PubMed ID: 24939539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical appraisal of inflammatory markers in cardiovascular risk stratification.
    Krintus M; Kozinski M; Kubica J; Sypniewska G
    Crit Rev Clin Lab Sci; 2014 Oct; 51(5):263-79. PubMed ID: 24918900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II).
    Möckel M; Müller R; Vollert J; Müller C; Danne O; Gareis R; Störk T; Dietz R; Koenig W
    Clin Res Cardiol; 2007 Sep; 96(9):604-12. PubMed ID: 17593313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.